Nearly 70% of autoimmune disease patients in India are women. Doctors have observed that autoimmune diseases are far more common among women, especially between the ages of 20 and 50, when hormonal and lifestyle factors are most active.
Established in 1977, The Hindu Temple Society of North America Sri Maha Vallabha Ganapati Devasthanam, popularly known as the Ganesh temple, is regarded as the first and oldest Hindu temple in North America.
The Congress said that the move is meant to keep away candidates who are not serious.
The systemic inflammatory response to SARS-CoV-2 adversely impacts the musculoskeletal system. Inflammatory molecules break the muscle fiber protein and decrease muscle protein synthesis leading to decreased muscle strength and also weaken bones.
More than 90 police cars, fire brigade engines and other city government vehicles saluted Dr Uma Rani Madhusudana for her non-stop, tirelessly devoted work in the care of COVID-19 patients at a hospital over 8 difficult and dangerous days.
Dr Uma Mysorekar, president of the Hindu Temple Society of North America will offer 'responsive prayers' at the special service which will "symbolise America's traditions of religious tolerance and freedom", the Presidential Inaugural Committee said. "The National Prayer Service, which will embody the themes of tolerance, unity and understanding, is a worship service for all Americans," he said.
The H1N1 virus is all that we get to talk or read about now days. While the government continues to move pillar and post to ensure that this problem is brought under control, it also faces another problem -- the shortage of swine flu drug Tamiflu -- thanks to which the problem has risen to such an extent.
Mayor Bloomberg shared a breakfast chat with representatives of six major faiths at the Mayor's annual inter-faith meet. Hinduism was represented by Dr Uma Mysorekar of the Hindu Temple Society of North America and six other Krishna devotees.
Take our quiz to find out just how much of a news wiz you are.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances